P

Protagonist Therapeutics
D

PTGX

46.450
USD
4.75
(11.39%)
Market Closed
Volume
38,647
EPS
2
Div Yield
-
P/E
17
Market Cap
2,768,327,936
OverviewSignalsIdeasNews
Related Instruments
    A
    AKRO
    -1.660
    (-5.58%)
    28.070 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    65.635 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    G
    G
    -0.310
    (-0.69%)
    44.780 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    K
    KYMR
    -4.040
    (-8.79%)
    41.930 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Protagonist Therapeutics

Sector: Healthcare
Industry: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.